Relevant Interviews, Webinar and Trial Updates posted by CRISPR Medicine News.
Always stay updated with the free CMN Newsletter.
Synthego supports CRISPR-edited cell and gene therapeutic development at every step, from R&D through IND submission to first-in-human trials
Support Research, Pre-Clinical & Clinical
Technology | Tool
Genome engineering products and services that support clients from discovery to clinic
Redwood City, California, USA
Kevin Holden, Ph.D., Head of Science, Synthego, firstname.lastname@example.org
Synthego is a genome engineering company that enables life science research and the development of genomic medicines. With unparalleled CRISPR expertise, state-of-the-art GMP capabilities, and a continuum of product offerings, Synthego supports the development of cell therapies at every step, from R&D through IND submission to first-in-human clinical trials.
High-Quality Clinical-Grade sgRNA for CRISPR-Based Therapies